Your browser doesn't support javascript.
loading
RNF219 Promotes Nasopharyngeal Carcinoma Progression by Activating the NF-κB Pathway.
Li, Xiang-De; Zhong, Qiu-Lu; Luo, Dan-Jing; Liang, Qian-Fu; Qiu, Jia-Qi; Du, Qing-Hua; Xiao, Liegang; Zhou, Yan-Hua; Long, Yao-Bin; Liu, Wen-Qi; Li, Jian.
Afiliación
  • Li XD; Department of Radiation Oncology, The Second Affiliated Hospital of Guangxi Medical University, No. 166 East University Road, Nanning, 530007, China.
  • Zhong QL; Department of Radiation Oncology, The Second Affiliated Hospital of Guangxi Medical University, No. 166 East University Road, Nanning, 530007, China.
  • Luo DJ; Department of Radiation Oncology, The Second Affiliated Hospital of Guangxi Medical University, No. 166 East University Road, Nanning, 530007, China.
  • Liang QF; Department of Radiation Oncology, The Second Affiliated Hospital of Guangxi Medical University, No. 166 East University Road, Nanning, 530007, China.
  • Qiu JQ; Department of Rehabilitation, The Second Affiliated Hospital of Guangxi Medical University, Guangxi, 530007, China.
  • Du QH; Department of Radiation Oncology, The Second Affiliated Hospital of Guangxi Medical University, No. 166 East University Road, Nanning, 530007, China.
  • Xiao L; Physical Examination Center, The Second Affiliated Hospital of Guangxi Medical University, Guangxi, 530007, China.
  • Zhou YH; Department of Radiation Oncology, The Second Affiliated Hospital of Guangxi Medical University, No. 166 East University Road, Nanning, 530007, China.
  • Long YB; Department of Radiation Oncology, The Second Affiliated Hospital of Guangxi Medical University, No. 166 East University Road, Nanning, 530007, China.
  • Liu WQ; Department of Radiation Oncology, The Second Affiliated Hospital of Guangxi Medical University, No. 166 East University Road, Nanning, 530007, China. wqliu988@163.com.
  • Li J; Department of Radiation Oncology, The Second Affiliated Hospital of Guangxi Medical University, No. 166 East University Road, Nanning, 530007, China. 13978896800@163.com.
Mol Biotechnol ; 65(8): 1318-1326, 2023 Aug.
Article en En | MEDLINE | ID: mdl-36512252

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Nasofaríngeas / FN-kappa B Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mol Biotechnol Asunto de la revista: BIOLOGIA MOLECULAR / BIOTECNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Nasofaríngeas / FN-kappa B Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mol Biotechnol Asunto de la revista: BIOLOGIA MOLECULAR / BIOTECNOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza